Day R O, Geisslinger G, Paull P, Williams K M
Department of Clinical Pharmacology and Toxicology, St. Vincent's Hospital Sydney, Australia.
Int J Clin Pharmacol Ther. 1995 May;33(5):308-10.
There was no significant difference in the pharmacokinetic parameters of tolbutamide (500 mg) determined before and after 14 days treatment with tenoxicam (20 mg/day) in 7 healthy volunteers (6 male, 1 female). In addition, co-administration of tenoxicam did not alter blood glucose concentrations.
在7名健康志愿者(6名男性,1名女性)中,用替诺昔康(20毫克/天)治疗14天前后测定的甲苯磺丁脲(500毫克)的药代动力学参数没有显著差异。此外,替诺昔康的联合给药并未改变血糖浓度。